Director I, Strategic Change Enablement
abbvie
Umowa o pracęPełny etatOpublikowano 3 października 2026
Źródło: About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
A sustainable process development and continuous improvement strategy is an integral part of a Quality Management System in GCP governing Research & Development (R&D). The Compliance Learning Change Management (CLCM) organization resides within Clinical Development Operations to sustain an interconnected process and operations ecosystem by seamlessly empowering teams to connect ideas and create meaningful impact.
The Director, Strategic Change Enablement (SCE) leads a team focused on delivery of Process and Change Management strategy and execution. The Director, SCE is responsible for leading global programs and initiatives driving clinical process infrastructure and continuous process improvement. This role partners with key stakeholders to ensure that SCE effectively delivers change management.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.
A sustainable process development and continuous improvement strategy is an integral part of a Quality Management System in GCP governing Research & Development (R&D). The Compliance Learning Change Management (CLCM) organization resides within Clinical Development Operations to sustain an interconnected process and operations ecosystem by seamlessly empowering teams to connect ideas and create meaningful impact.
The Director, Strategic Change Enablement (SCE) leads a team focused on delivery of Process and Change Management strategy and execution. The Director, SCE is responsible for leading global programs and initiatives driving clinical process infrastructure and continuous process improvement. This role partners with key stakeholders to ensure that SCE effectively delivers change management.
